Phosphofructokinase, Liver (PFKL) Peptide
-
- Target See all PFKL products
- PFKL (Phosphofructokinase, Liver (PFKL))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PFKL antibody (Catalog #: ARP45774_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PFKL (Phosphofructokinase, Liver (PFKL))
- Synonyms
- PFK-B Peptide, AA407869 Peptide, phosphofructokinase, liver type Peptide, phosphofructokinase, liver, B-type Peptide, PFKL Peptide, Pfkl Peptide
- Background
-
Phosphofructokinase (PFK) is a tetrameric enzyme that catalyzes a key step in glycolysis, namely the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate. PFK from muscle is a homotetramer of M subunit, PFK from liver is a homotetramer of L-subunits, while PFK from platelets can be composed of any tetrameric combination of M and L subunits. PFKL represents the L subunit.
Alias Symbols: DKFZp686G1648, DKFZp686L2097, FLJ30173, FLJ40909, PFK-B
Protein Interaction Partner: ATN1,COPS6,KRTAP4-12,PFKM,PRPF40A,COPS6,DMWD,KRTAP4-12,TAF10,TAF13
Protein Size: 568 - Molecular Weight
- 64 kDa
- Gene ID
- 5211
- NCBI Accession
- NM_002626
- UniProt
- Q7L2M7
-